HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immune evasion in HPV- head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss.

Abstract
An aneuploid-immune paradox encompasses somatic copy-number alterations (SCNAs), unleashing a cytotoxic response in experimental precancer systems, while conversely being associated with immune suppression and cytotoxic-cell depletion in human tumors, especially head and neck cancer (HNSC). We present evidence from patient samples and cell lines that alterations in chromosome dosage contribute to an immune hot-to-cold switch during human papillomavirus-negative (HPV-) head and neck tumorigenesis. Overall SCNA (aneuploidy) level was associated with increased CD3+ and CD8+ T cell microenvironments in precancer (mostly CD3+, linked to trisomy and aneuploidy), but with T cell-deficient tumors. Early lesions with 9p21.3 loss were associated with depletion of cytotoxic T cell infiltration in TP53 mutant tumors; and with aneuploidy were associated with increased NK-cell infiltration. The strongest driver of cytotoxic T cell and Immune Score depletion in oral cancer was 9p-arm level loss, promoting profound decreases of pivotal IFN-γ-related chemokines (e.g., CXCL9) and pathway genes. Chromosome 9p21.3 deletion contributed mainly to cell-intrinsic senescence suppression, but deletion of the entire arm was necessary to diminish levels of cytokine, JAK-STAT, and Hallmark NF-κB pathways. Finally, 9p arm-level loss and JAK2-PD-L1 codeletion (at 9p24) were predictive markers of poor survival in recurrent HPV- HNSC after anti-PD-1 therapy; likely amplified by independent aneuploidy-induced immune-cold microenvironments observed here. We hypothesize that 9p21.3 arm-loss expansion and epistatic interactions allow oral precancer cells to acquire properties to overcome a proimmunogenic aneuploid checkpoint, transform and invade. These findings enable distinct HNSC interception and precision-therapeutic approaches, concepts that may apply to other CN-driven neoplastic, immune or aneuploid diseases, and immunotherapies.
AuthorsWilliam N William Jr, Xin Zhao, Joy J Bianchi, Heather Y Lin, Pan Cheng, J Jack Lee, Hannah Carter, Ludmil B Alexandrov, Jim P Abraham, David B Spetzler, Steven M Dubinett, Don W Cleveland, Webster Cavenee, Teresa Davoli, Scott M Lippman
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 118 Issue 19 (05 11 2021) ISSN: 1091-6490 [Electronic] United States
PMID33952700 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • B7-H1 Antigen
  • CD274 protein, human
  • CD3 Complex
  • Cytokines
  • JAK2 protein, human
  • Janus Kinase 2
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Aneuploidy
  • B7-H1 Antigen
  • CD3 Complex
  • CD8-Positive T-Lymphocytes
  • Cell Line, Tumor
  • Chromosome Deletion
  • Chromosomes
  • Cytokines
  • DNA Copy Number Variations
  • Gene Expression Regulation, Neoplastic
  • Genes, p53 (genetics)
  • Head and Neck Neoplasms (genetics)
  • Humans
  • Immune Evasion (genetics)
  • Immunotherapy
  • Janus Kinase 2
  • Middle Aged
  • Papillomavirus Infections (genetics)
  • T-Lymphocytes, Cytotoxic
  • Tumor Microenvironment
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: